Bayonet Tech BNTX, + 4.54% And Pfizer Inc. PFE, + 1.00%, Candidates developing the Covid-19 vaccine said in a news release on Wednesday that they plan to conduct a regulatory review for BNT 162B2 in October based on the success of the vaccine in late-stage clinical trials. However, the companies …
Read More »Bayonet Tech, Pfizer expects clinical ‘response’ to coronavirus vaccine in late October
